HC_meetings_HPHC_MMS 1-22-20_FINAL_PPT

3/2/2020

since 8/2018 – Goal: Finish network rollout by end of 2020 • Non-CAQH: Quarterly reminders … uncertainty for Life Sciences companies, as does the 2020 election cycle ▪ If stakeholders cannot …

/Governance-and-Leadership/Board-of-Trustees/HC_meetings_HPHC_MMS-1-22-20_FINAL_PPT/

VitalSigns_JanFeb_2020_

1/31/2020

/Publications/Vital-Signs---Member-Publication/VitalSigns_JanFeb_2020_/

Testimony Relative to an Act to Improve Health Care by Investing in Value Before the Joint Committee on Health Care Financing

1/20/2020

or access to care. For other sections, support may come with qualifications, but the shared end goal should … pathway to the shared end goal. For example, the Medical Society strongly supports the patient protections … programs.  To that end, HPC has played a tremendously valuable role in health care cost containment …

/Advocacy/State-Advocacy/State-Testimony/Testimony-Relative-to-an-Act-to-Improve-Health-Care-by-Investing-in-Value-Before-the-Joint-Committee-on-Health-Care-Financing/

1polypharmacy slides PDF

1/16/2020

meds ➢ Review all medications ➢ Identify risk of medications ➢ Estimate life expectancy … EMPOWER ➢ Eliminating Medications Through Patient Ownership of End Results ➢ 50% MDs continue … for Discontinuation: • No valid indication • Time of life expectancy less than benefit of medication • Risk …

/Continuing-Education-and-Events/Online-CME/Courses/From-Polypharmacy-A-Wise-Choice/1polypharmacy-slides-PDF/

Committee on Public Health - January 16, 2020

1/16/2020

Attendance Nicolas Argy, MD, JD Julia A. Benedetti, MD Libby Bradshaw, DO James Broadhurst, MD, Chair Catherine Brown, DVM Al DeMaria, MD Louis Fazen, III, MD, MPH Eric Goralnick, MD Barbara Herbert, MD Nancy Hurley, MD Janet Jankowiak, MD Michael Lew, MD Richard Lu Paula Madison Lisa Matthews, MD Barbar

/Governance-and-Leadership/Committees,-Task-Forces-and-Sections/Committee-on-Public-Health---January-16,-2020/

PolyPharmacy Slides

1/15/2020

to stop meds Review all medications Identify risk of medications Estimate life expectancy Define … EMPOWER Eliminating Medications Through Patient Ownership of End Results 50% MDs continue …: No valid indication Time of life expectancy less than benefit of medication Risk of harm No symptom …

/Continuing-Education-and-Events/Online-CME/Courses/From-Polypharmacy-A-Wise-Choice/PolyPharmacy-Slides/

Medical Decision-Making

12/9/2019

for life-sustaining treatments near the end of life Establishment and maintenance of a national database for advance … and Policies and procedures that honor patients’ choices, goals, and values throughout life Individuals being … for Life Sustaining Treatment (POLST) Program, which assists individuals in communicating their preferences …

/Advocacy/Key-Issues/Medical-Decision-Making/Medical-Decision-Making/

Combined ABC 2019

12/6/2019

/Interim-Meeting/Combined-ABC-2019/

Committee on Geriatric Medicine - September 11, 2019

11/20/2019

/Templates/Article.aspx?id=4294984148

Committee on Violence Intervention and Prevention - November 18, 2019

11/18/2019

Attendees Wendy Macias-Konstantopoulos, MD, MPH, chair, presiding Elaine J. Alpert, MD, MPH Christopher E. Barsotti, MD Ylisabyth S. Bradshaw, DO, MS Staff Candace Savage Administrative Approval of Minutes The minutes of the meetings of September 9, 2019 were reviewed and approved as

/Templates/Article.aspx?id=4294985129